Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms

Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms

 

Program Overview
Join the discussion with our faculty as they present the most up-to-date information being reported in clinical trials for the new calcitonin gene-related peptide (CGRP) inhibitors. Whether you’re learning this information for the first time or you want to hear more of the newest information about how CGRP inhibitors may change your practice, you’ll leave this session with a new insight into how what’s happening in clinical trials today will impact your practice in the near future. This enduring program was streamed live from Headache Update 2017.

Learning Objectives
After completing this activity, the participant should be better able to:

  • Outline current challenges and barriers to the effective prevention of migraine
  • Describe the role of calcitonin gene-related peptide
  • Summarize data focusing on new and emerging preventive treatments for episodic and chronic migraine

Faculty/Planning Committee

Merle L. Diamond, MD – Chair
President, Managing Director
Diamond Headache Clinic
Chicago, Illinois

Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Release/Expiration Dates
Release Date: August 1, 2017
Expiration Date: August 1, 2018

CME CREDIT
Accreditation Statement
: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-17-162-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.

NURSING CREDIT
Accreditation Statement
: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 17-162-062

Activity provided by MediCom Worldwide, Inc.

Published on Primary Issues, 8/11/2017

Participant will be leaving Primary Issues and completing this activity on the hosts website (Emerging Solutions in Pain).


0 Comment

Would you like to join the discussion? Feel free to contribute!

Write a Reply or Comment

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Overview of the Opioi… July 25, 2017 Faculty Spotlight: Dr… August 8, 2017